Ligand Pharma (LGND) Reports FDA Approval of Promacta/Revolade sNDA
Tweet Send to a Friend
Ligand Pharma (Nasdaq: LGND) announced that its partner GlaxoSmithKline (NYSE: GSK) plc has received approval of a supplemental New Drug ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE